Fidelity Investments
SPHS

Fidelity Investments’s Sophiris Bio, Inc. SPHS Stock Holding History

Fidelity Investments’s Portfolio SPHS Stock Details SPHS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-1,431,268
Closed -$4.77M – 2896
2014
Q1 		$4.77M Hold
1,431,268
– – ﹤0.01% 2221
2013
Q4 		$6.09M Hold
1,431,268
– – ﹤0.01% 2116
2013
Q3 		$6.53M Buy
+1,431,268
New +$6.6M ﹤0.01% 2077

Other funds holding SPHS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
SC
Sophrosyne Capital New York $11.5M AUM 17.82% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Fidelity Investments's SPHS Position: Q2 2014 in Review

Fidelity Investments sold out of Sophiris Bio, Inc. (SPHS) in Q2 2014, closing a stake of 1,431,268 shares — an estimated $4.77M sold.

Fidelity Investments first reported a position in SPHS in Q3 2013 and held it in 3 quarters. The position peaked at $6.53M in Q3 2013. 18 funds tracked by Wall St. Rank hold SPHS as of Q2 2014.

  • Fidelity Investments reported no remaining Sophiris Bio, Inc. position as of Q2 2014 after selling out during the quarter.
  • Fidelity Investments sold 1,431,268 Sophiris Bio, Inc. shares in Q2 2014, an estimated $4.77M.
  • Fidelity Investments first reported a position in Sophiris Bio, Inc. in Q3 2013 and held it in 3 quarters.
  • Fidelity Investments's Sophiris Bio, Inc. position peaked at $6.53M in Q3 2013.
  • 18 funds tracked by Wall St. Rank held Sophiris Bio, Inc. as of Q2 2014.

Based on Fidelity Investments's 13F filing for Q2 2014, filed 14 Aug 2014.